Both in Pharmaceuticals

Genelux vs vTv Therapeutics

Over the past year GNLX returned −71.1% and VTVT returned +23.1%; their daily moves had a correlation of 0.06.

GNLX −71.1% VTVT +23.1%Growth of $1, one year, split-adjusted
MetricGNLXVTVT
Price$2.21$25.72
Market cap$100.0M$101.7M
Today+7.80%0.00%
1 month−9.8%−14.3%
6 months−11.6%−17.7%
Year to date−49.3%−35.7%
1 year−69.7%—
Revenue growth (YoY)——
Gross margin——
Net margin——
P/E (TTM)——
Price / sales12,499.0×2.8×
Net cash$18.7M$86.6M
Dividend yield——
Volatility (60d)70.3%42.9%
Short % of float12.1%9.7%
Next earnings——

Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).